Best of the cancer meetings after dust settles? The widening approval of MABs in the cancer treatment mix...the ability of MABs to carry a payload and deposit it selectively at specific disease sites. Why did PPHM progress notes pass muster with the oncology treatment specialists and researchers? It starts with the dreams and thoughts of a scientist totally in touch with the latest in his field...one who knows how to build a better MAb,a veritable intravenous rocket. From the inventor's brain to the pharmacy shelf is the journey we're on, and PPHM appears to have a good product and smoothly functioning team. Good work!
News 
Market Data 
Discover 
AI
